Last edition
News about Market
Strategic Licensing Boost: Emcure Gains Commercial Rights for Roche Brands in India
Under the agreement, Emcure will acquire commercial rights to several branded prescription medicines used in the management of kidney diseases and in post-transplant care for patients in India. The deal strengthens Emcure’s presence in high-priority therapeutic areas and expands its portfolio in nephrology and transplant medicine.
Market | 03/03/2026 | By Darshana | 175
SciBase Holding AB Secures US FDA Approval to Expand Nevisense Use Beyond Dermatologists
U.S. Food and Drug Administration clears expanded labelling for Nevisense, enabling trained healthcare professionals to perform procedures, improving clinic workflow integration and supporting broader melanoma diagnostic access across the United States.
Market | 03/03/2026 | By News Bureau | 115
Cipla Launches Saxenda for Weight Management
Cipla has strengthened its US portfolio with the launch of a generic version of Saxenda (liraglutide injection), indicated for chronic weight management. The launch follows ANDA approval from the US Food and Drug Administration (FDA), granted to its partner Orbicular, paving the way for expanded access to a more affordable GLP-1 therapy in the US.
Market | 02/03/2026 | By News Bureau | 165
IISc-Led Pravriddhi Backs Indigenous Compressor Technology for Quality-Critical Industries
Pravriddhi, the pan-India product accelerator led by the Foundation for Science Innovation and Development (FSID) at the Indian Institute of Science (IISc), Bengaluru, has announced the launch of India’s first oil-free water-injected screw compressor, HYDRINO.
Market | 27/02/2026 | By Darshana
Lupin Limited Secures US FDA Approval for Generic Brivaracetam Oral Solution
Lupin has received US FDA approval for its generic brivaracetam oral solution, bioequivalent to Briviact, and has launched the product in the US market targeting partial-onset seizures.
Market | 25/02/2026 | By News Bureau | 212
Integris Medtech Secures SEBI Nod for INR 925 Crore IPO
Integris Medtech, the second-largest Indian-headquartered diversified medical technology platform by operating revenue in FY25, has received approval from the Securities and Exchange Board of India (SEBI) to proceed with its proposed initial public offering (IPO).
Market | 25/02/2026 | By Darshana | 184
Frontier Biotechnologies Inc. Signs USD 1 Billion siRNA Licensing Deal with GSK
Frontier Biotech has granted GSK exclusive global rights to two siRNA drug candidates in a deal worth up to USD 1 billion, strengthening its international expansion and immunology pipeline focus.
Market | 25/02/2026 | By News Bureau | 228
Lupin Secures European Commission Approval for Ranluspec, Biosimilar Ranibizumab
European Commission clears Lupin’s biosimilar ranibizumab, Ranluspec, for multiple retinal disorders; Sandoz to commercialise across the EU, expanding access to affordable biologics.
Market | 24/02/2026 | By News Bureau | 133
Morepen Bags INR 825 Crore Global Deal
Morepen has secured a ?825 crore global deal, marking its expansion into the high-growth Contract Development and Manufacturing Organisation (CDMO) segment.
Market | 24/02/2026 | By News Bureau | 123
Exclusive licensing deal grants Arrotex rights to market clobetasol propionate ophthalmic suspension for post-surgical ocular inflammation and pain, expanding Formosa’s footprint in Oceania.
Market | 23/02/2026 | By News Bureau | 124
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy